Investor Presentation Q1 2018 slide image

Investor Presentation Q1 2018

Investor Presentation First three months of 2018 Slide 20 Appendix 1. Novo Nordisk at a glance 2. Insulin 21 34 3. GLP-1 diabetes 58 4. Obesity 76 5. Biopharmaceuticals & Other serious chronic diseases 85 6. Financials 97 7. Sustainable business 109 changing diabetes® novo nordisk
View entire presentation